Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Mammalian hexokinases and their abnormal expression in cancer.

Smith TA.

Br J Biomed Sci. 2000;57(2):170-8. Review.

PMID:
10912295
2.

6-Deoxy-6-[18F]fluoro-D-fructose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Jul 10 [updated 2011 Oct 27].

3.

Indocyanine green derivative 02-2-deoxy-d-glucose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Sep 17 [updated 2012 Dec 20].

4.

Cypate-2-Deoxy-d-glucose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Aug 18 [updated 2012 Nov 15].

5.

[18F]Fluoro-2-deoxy-2-D-glucose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2004 Oct 1 [updated 2005 Jan 12].

6.

99mTc-Ethylenedicysteine-deoxyglucose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Oct 17 [updated 2010 Feb 16].

7.

IRDye800-2-Deoxy-D-glucose.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 May 17 [updated 2009 Jul 24].

8.

[Targeting the gene of glucose metabolism for the treatment of advanced gliomas].

Oudard S, Miccoli L, Dutrillaux B, Poupon MF.

Bull Cancer. 1998 Jul;85(7):622-6. Review. French.

9.

HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R.

Mini Rev Med Chem. 2009 Aug;9(9):1084-101. Review.

PMID:
19689405
10.

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.

Mathupala SP, Ko YH, Pedersen PL.

Semin Cancer Biol. 2009 Feb;19(1):17-24. doi: 10.1016/j.semcancer.2008.11.006. Epub 2008 Dec 3. Review.

11.
12.

PET/CT for the staging and follow-up of patients with malignancies.

Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.

Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29. Review.

PMID:
19406595
13.

Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.

Robey RB, Hay N.

Oncogene. 2006 Aug 7;25(34):4683-96. Review.

PMID:
16892082
14.
15.

Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.

Krasnov GS, Dmitriev AA, Lakunina VA, Kirpiy AA, Kudryavtseva AV.

Expert Opin Ther Targets. 2013 Oct;17(10):1221-33. doi: 10.1517/14728222.2013.833607. Epub 2013 Aug 28. Review.

PMID:
23984984
16.

The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies.

Mathupala SP, Ko YH, Pedersen PL.

Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1225-30. doi: 10.1016/j.bbabio.2010.03.025. Epub 2010 Apr 8. Review.

17.

Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma.

Zhong JT, Zhou SH.

Oncotarget. 2017 Feb 21;8(8):14133-14146. doi: 10.18632/oncotarget.13044. Review.

Supplemental Content

Support Center